| # | Drug | Count |
|---|---|---|
| 0 | TRAMETINIB | 7 |
| 1 | RITUXIMAB | 6 |
| 2 | BEVACIZUMAB | 5 |
| 3 | IBRUTINIB | 5 |
| 4 | TEBENTAFUSP | 5 |
| 5 | ATENOLOL | 4 |
| 6 | CHLORAMBUCIL | 4 |
| 7 | DEXAMETHASONE | 4 |
| 8 | DEXAMETHASONE 1.5 MG | 4 |
| 9 | ESCITALOPRAM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-TTWE | 2 | 0.0105 |
| 1 | TEBENTAFUSP | 5 | 0.0083 |
| 2 | BELINOSTAT | 1 | 0.0028 |
| 3 | PONESIMOD | 1 | 0.0023 |
| 4 | LAROTRECTINIB | 1 | 0.0011 |
| 5 | CHLORAMBUCIL | 4 | 0.0010 |
| 6 | PRALSETINIB | 1 | 0.0005 |
| 7 | ACETAZOLAMIDE SODIUM | 3 | 0.0005 |
| 8 | TRETINOIN | 3 | 0.0004 |
| 9 | TRAMETINIB | 7 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 5 | 0.0083 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 3 | 0.0001 |
| 3 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Interleukin-12 Antagonist [EPC] | 4 | 0.0000 |
| 7 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |